, Singapore
278 views
Photo from ScaleUp Bio.

ScaleUp Bio secures permit for commercial food production facility

The facility will cover around 2,266 square metres.

Authorities have granted ScaleUp Bio a food manufacturing licence for its commercial pilot production facility in Tuas, western Singapore.

In a statement, the company said the facility will cover a footprint of around 2,266 square metres and will give food innovators access to up to 10,000 litres of fermentation and associated downstream processing capacity. 

ScaleUp Bio said it is now one of the CDMOs in the world approved as a food manufacturing facility.

“ScaleUp Bio’s value proposition offers anyone with the next best concept in food to bring that idea to reality, and to pilot stage commercial production in Singapore, backed by a blue-chip corporate ecosystem of support. With this milestone, we are moving one step forward towards enabling the next food revolution,” said ScaleUp Bio CEO Francisco Codoñer.

The new facility complements ScaleUp Bio’s Fermentation Joint Lab, the company said. This facility offers start-ups up to 100 litres of fermentation capacity in a dedicated food-grade, scientific research laboratory.

ALSO READ: ION Orchard leads charge in sustainable takeaway practices

Aside from the facility, Codoñer said food innovators can also take advantage of the corporate network of ScaleUp Bio’s parent companies ADM and Nurasa.

Join Singapore Business Review community
Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Top News

September surge masks looming export slowdown to 6% in 2027
Maybank raised its 2026 forecast to 27% from 18% in the same report.Non-oil domestic exports (NODX) growth could slow to 6% in 2027 as supply chain pressures and higher financing costs weigh on shipment momentum, Maybank Research Pte Ltd said.
Economy